YM WANG1, G ZHANG1, JH Zhou1, M HU2, Y WANG2, Q CAO2, G ZHENG2, GREY ST3, DC Harris2, SI Alexander1

1Centre for Kidney Research, The Children’s Hospital at Westmead, Sydney, Australia. 2Centre for Transplant and Renal Research, The University of Sydney at Westmead Hospital; 3Transplantation Immunology Group, Garvan Institute of Medical Research, Sydney, Australia.

Aim: To evaluate whether innate lymphoid cells 2 (ILC2) expansion by IL-33 exacerbates IgA prone BAFF-transgenic (BAFF-Tg) mice.

Background: B-cell activating factor (BAFF) belongs to the tumor necrosis factor (TNF) ligand family. BAFF plays a central role in the proliferation and differentiation of B cells. Excessive levels of BAFF cause abnormally high antibody production, including IgA. IL-33 is a new member of the IL-1 superfamily of cytokines, which is a crucial activator of ILC2s in innate immunity and allergic inflammation.

Methods: 12-16 week old BAFF-Tg mice were injected with IL-33 (0.5ug per mouse) daily for five days. Histology and IgA expression in kidneys and spleens were evaluated at 6 weeks after IL-33 injection. B cells were measured in PBMC and spleens; ILC2 cells were evaluated from kidneys and gut. Kidney function and damage was assessed by urine protein and serum creatinine.

Results: IL-33-treated BAFF-Tg mice showed significantly higher levels of proteinuria and serum creatinine compared to untreated BAFF-Tg (p<0.05). There was significantly more glomerulosclerosis, tubular damage and interstitial infiltrates in the IL-33-treated group (p<0.01). There was an increased level of CD19 B cells in spleen, but unchanged ILC2 cell numbers in kidney and gut. Furthermore, there was increased IgA expression in glomeruli of IL-33-treated BAFF-Tg mice compared with non-treated BAFF-Tg mice.

Conclusions: IL-33 exacerbates renal injury in BAFF-Tg mice with development of IgA glomerulonephritis possibly through enhanced IgA production. This suggests a potential role for IL-33 and possibly ILC2s in the pathogenesis of IgA glomerulonephritis.


The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd